Article info
PDFReview
Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS): genetic and clinical aspects
- Correspondence to Dr Andrea Cortese, Neuromuscular diseases, University College London Institute of Neurology, London, UK; andrea.cortese{at}ucl.ac.uk; Professor Mary M Reilly; m.reilly{at}ucl.ac.uk
Citation
Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS): genetic and clinical aspects
Publication history
- Accepted May 28, 2021
- First published August 13, 2021.
Online issue publication
January 20, 2022
Article Versions
- Previous version (20 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS): diagnostic contribution of vestibular function tests
- Diagnostic yield of testing for RFC1 repeat expansions in patients with unexplained adult-onset cerebellar ataxia
- Sensory neuronopathies: new genes, new antibodies and new concepts
- Can CANVAS due to RFC1 biallelic expansions present with pure ataxia?
- RFC1-related ataxia is a mimic of early multiple system atrophy
- Intronic FGF14 GAA repeat expansions are a common cause of ataxia syndromes with neuropathy and bilateral vestibulopathy
- Diagnosis and management of progressive ataxia in adults
- RFC1 CANVAS: the expanding phenotype
- Bilateral vestibulopathy presaging clinically probable multisystem atrophy
- 15.45 Recessive pentanucleotide repeat expansion in RFC1 causes CANVAS and late-onset sensory ataxia